Directory
>
Mark Lappe
Mark Lappe
CEO | Inhibrx Biosciences, Inc.
California, United States
Mark Lappe
Summary
Mark Lappe is a seasoned executive in the biopharmaceutical and biotechnology sectors, currently serving as the CEO of Inhibrx, a company focused on advancing drug development and commercialization. With extensive expertise in clinical development, regulatory affairs, and molecular biology, he has a proven track record of leading innovative projects in life sciences. His leadership is characterized by a strong emphasis on technology transfer and the development of cutting-edge diagnostics and therapies. Mark's strategic vision and understanding of the pharmaceutical landscape enable him to navigate complex challenges and drive growth in competitive markets. He is passionate about fostering collaboration within teams and promoting a culture of continuous learning and innovation. Mark's commitment to advancing healthcare solutions is evident in his work with start-ups and established firms alike. He is dedicated to improving patient outcomes through effective drug discovery and development processes. Mark's influence extends beyond his immediate role, as he actively engages in discussions about the future of biotechnology and its impact on society.
Mark Lappe
Work Experience
CEO at
Inhibrx Biosciences, Inc.
Present
Frequently Asked Questions about Mark Lappe
What is Mark Lappe email address?
Mark Lappe's primary email address is ****@inhibrx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Lappe work for?
Mark Lappe is a CEO at Inhibrx Biosciences, Inc., a company specializing in Commercial physical research.
How can I directly contact Mark Lappe?
To contact Mark Lappe directly, you can use the email address ****@inhibrx.com. Complete contact information is available upon registration with Muraena.
Who is Mark Lappe?
Mark Lappe is a seasoned executive in the biopharmaceutical and biotechnology sectors, currently serving as the CEO of Inhibrx, a company focused on advancing drug development and commercialization. With extensive expertise in clinical development, regulatory affairs, and molecular biology, he has a proven track record of leading innovative projects in life sciences. His leadership is characterized by a strong emphasis on technology transfer and the development of cutting-edge diagnostics and therapies. Mark's strategic vision and understanding of the pharmaceutical landscape enable him to navigate complex challenges and drive growth in competitive markets. He is passionate about fostering collaboration within teams and promoting a culture of continuous learning and innovation. Mark's commitment to advancing healthcare solutions is evident in his work with start-ups and established firms alike. He is dedicated to improving patient outcomes through effective drug discovery and development processes. Mark's influence extends beyond his immediate role, as he actively engages in discussions about the future of biotechnology and its impact on society.
Mark`s contact details
****@inhibrx.com
Colleagues
EVP, Chief Clinical Development Officer at Inhibrx
Evp, Chief Technical Operations Officer
Executive Director, Regulatory Operations
Vice President - Analytical Development and Quality Control
Vice President Regulatory Affairs
EVP, Chief Commercial and Business Development Officer
Chief Scientific Officer & EVP Corporate Strategy